Navigation Links
STELARA® Awarded 2011 Prix Galien USA in Best Biotechnology Product Category
Date:9/28/2011

/p>

STELARA® is a prescription medicine that affects your immune system. STELARA® can increase your chance of having serious side effects including:

Serious Infections

STELARA® may lower your ability to fight infections and may increase your risk of infections. While taking STELARA®, some people have serious infections, which may require hospitalization, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses.

  • Your doctor should check you for TB before starting STELARA® and watch you closely for signs and symptoms of TB during treatment with STELARA®.
  • If your doctor feels that you are at risk for TB, you may be treated for TB before and during treatment with STELARA®.

You should not start taking STELARA® if you have any kind of infection unless your doctor says it is okay.

Before starting STELARA®, tell your doctor if you think you have an infection or have symptoms of an infection such as:

  • fever, sweats, or chills
  • muscle aches
  • cough
  • shortness of breath
  • blood in your phlegm
  • weight loss
  • warm, red, or painful skin or sores on your body
  • diarrhea or stomach pain
  • burning when you urinate or urinate more often than normal
  • feel very tired
  • are being treated for an infection
  • get a lot of infections or have infections that keep coming back
  • have TB, or have been in close contact with someone who has TB

After starting STELARA®, call your doctor right away if you have any symptoms of an infection (see above).

STELARA® can make you more likely to get infections or make an infection that you have worse. People who
'/>"/>

SOURCE Janssen Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis
2. University of Michigan Pediatric Device Inventors Awarded Funds to Design Child-Specific Medical Devices
3. PharmAthene Awarded 50% Profit Split on Worldwide Sales of Smallpox Antiviral Therapy by Delaware Chancery Court
4. Inogen Awarded Contract to Service TRICARE West Oxygen Therapy Patients
5. Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management
6. Elusys Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection
7. Sanmina-SCI Kenosha, Wisconsin Facility Awarded ISO 13485 Certification for Medical Devices
8. Eurotech Awarded 1.5M USD Contract to Supply Embedded Computers for Medical Application
9. USANA Awarded the NutriSearch Gold Medal of Achievement™
10. Avaxia Biologics, Inc. Awarded BARDA Contract for Therapeutic Countermeasure to Help the Nation Respond to a Radiological Emergency
11. Inogen Awarded Department of Veterans Affairs Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or the "Company"), a ... products and a licensed producer ("LP") to cultivate marijuana ... Canada ) ("MMPR"), is pleased to announce that ... the transaction announced on March 11, 2015 with Medna ... a total of 20,156,790 common shares of T-Bird (45% ...
(Date:4/23/2015)...  Edwards Lifesciences Corporation (NYSE: EW ), the ... hemodynamic monitoring, today reported net income for the quarter ... diluted share.  Net income for the same period a ... share, and non-GAAP net income was $82.1 million, or ... the quarter ended March 31, 2015 increased 13.0 percent to ...
(Date:4/23/2015)... 2015 Nektar Therapeutics (Nasdaq: NKTR ) will ... 31, 2015 on Thursday, April 30, 2015, after the close ... chief executive officer, will host a conference call to review ... Pacific Time (PT). The press release and ... accessed through a link that is posted on the home ...
Breaking Medicine Technology:T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 3Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After Close of U.S.-Based Financial Markets 2
... , , , , , , WOONSOCKET, R.I., Dec. ... select CVS/pharmacy stores are now offering H1N1 vaccine in 20 ... restrictions for receiving H1N1 vaccines continue, many states have lifted ... shot while supplies last. In addition, seasonal influenza vaccine ...
... SALT LAKE CITY, Dec. 16 TechniScan, Inc. ... device company engaged in the development and commercialization of an ... PhD, has been appointed to the TechniScan Board of Directors. ... experience running small to large medical devices companies, including GE ...
Cached Medicine Technology:CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 3CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 4In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors 2In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors 3
(Date:4/25/2015)... Parker and Sons projects growth in 2015. The ... Arizona alongside the growing economy. As a result, Parker and ... to help account for the rising need for heating, cooling, ... something we are enthusiastic about. It means growth for us, ... Parker and Sons. , Indeed, Parker and Sons has been ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 On Friday, ... of RFID Journal’s annual Best Implementation Award. This ... demonstrated the best use of RFID technology to improve ... is the company that best demonstrates how RFID is ... presented at RFID Journal Live! 2015 in San Diego, ...
(Date:4/24/2015)... Constellations Recovery celebrates the opening of the ... 35 miles from New York City, Constellations Recovery was ... while recovering from addiction. The Open House, which is ... doctors and treatment centers to see the residence, tour ... offered by Constellations Recovery.,  , The newly opened facility ...
(Date:4/24/2015)... Foothill Ranch, California (PRWEB) April 24, 2015 ... that has a wide range of capabilities and services ... etc. , Ryadon's Quantity Discount Program will be ... ) as follows: , Order 4-19: Receive 10% discount ... Can Benefit by Using the Drawer Slides Products, ...
(Date:4/24/2015)... 24, 2015 Lipitor lawsuits ( ... the federal multidistrict litigation underway in U.S. District ... documents, the parties involved in the proceeding submitted ... among other things, preparation for the litigation’s upcoming ... both plaintiffs and defendants have conducted depositions of ...
Breaking Medicine News(10 mins):Health News:Parker and Sons Plans to Expand in 2015 2Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 3Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3
... The following is a,statement by Reverend Carlton W. Veazey, ... "On the 35th anniversary of Roe v. Wade, ... that abortion will be safe, legal, and available,if and ... v. Carhart,opinion and the ,fetal personhood, initiatives and outright ...
... Inc, (TSX:,DAX) (NASDAQ: DRAX ) has received approval ... Normal Course Issuer Bid (NCIB) to,purchase up to 4,072,054 ... shares in the public float as at January 14, ... DRAXIS were issued and,outstanding., Purchases may begin on ...
... of Pharmaceutical and CRO Experience ... to Key Leadership Role, CINCINNATI, Jan. 16 Kendle ... (CRO), today,announced Dr. Ross J. Horsburgh has joined the company ... he will lead the,company,s overall expansion in Asia/Pacific and will ...
... (HCC) patients in China may be treated with Traditional ... its effectiveness. These stated that a research group in ... PTEN in HCC, which may suppress tumor cell growth ... research article published on January 7, 2008 in ...
... Universit Lavals Faculty of Medicine and Robert-Giffard Hospital has ... antipsychotic drugswhich in extreme cases can be as high ... through a specially designed weight control program. The researchers ... report the details of their findings in a recent ...
... for pepsin, a digestive enzyme specifically produced in the ... different biochemical and immunological properties, PGI and PGII. Serum ... and functional changes in the stomach, and used as ... has been focused on the identification of individuals for ...
Cached Medicine News:Health News:Statement of the Reverend Carlton W. Veazey, President and CEO of the Religious Coalition for Reproductive Choice, on the 35th Anniversary of Roe v. Wade 2Health News:DRAXIS Share Buyback Approved by TSX 2Health News:DRAXIS Share Buyback Approved by TSX 3Health News:DRAXIS Share Buyback Approved by TSX 4Health News:Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion 2Health News:Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion 3Health News:How does Fu-Zheng-Jie-Du-Decoction act on PTEN expression in hepatocellular carcinoma? 2Health News:Weight gain induced by antipsychotic drugs can be avoided 2Health News:What are the essential characteristics of serum PG in Chinese? 2
Angled 45 degree shafts with 10.5 mm tying platform. 1 mm of tip is crisscross serrated. Serrated handle with dull finish. Most popular size or model. Overall length 3.2 inches....
Angled shafts with 10 mm tying platform. True round knurled handle in the closed position with polished finish. Overall length 4.2 inches....
Angled 45 degree shafts 8 mm from tip to bend with 5 mm tying platform. Serrated handle with dull finish. Overall length 3.3 inches....
Ultra-fine 5 mm tying platform is valuable when manipulating delicate 10-0 and 11-0 sutures. Pin in handle keeps tips in alignment. Shafts available straight or angled 45 degrees, 8 mm from tip. Angl...
Medicine Products: